FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DUNN JEFFREY W
2. Issuer Name and Ticker or Trading Symbol

SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chairman, President & CEO
(Last)          (First)          (Middle)

C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101
3. Date of Earliest Transaction (MM/DD/YYYY)

11/4/2019
(Street)

SANTA CLARA, CA 95050
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/4/2019    S(1)    2600.00  D $19.0054 (2) 464940.00  I  by Trust (3)
Common Stock  11/5/2019    S(1)    37400.00  D $19.1718 (4) 427540.00  I  by Trust (3)
Common Stock                 92747.00 (5) D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
(2)  The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.01, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(3)  Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
(4)  The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
(5)  Includes 71,997 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DUNN JEFFREY W
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101
SANTA CLARA, CA 95050
X
Chairman, President & CEO

Signatures
/s/ Michael A. Pisetsky, Attorney-in-Fact for Jeffrey W. Dunn 11/6/2019
**Signature of Reporting Person Date


SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more SI BONE Charts.
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more SI BONE Charts.

Si-bone, Inc. News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
Monday 15 July 2024 (13 hours ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Friday 5 July 2024 (1 week ago) • Edgar (US Regulatory)
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
Wednesday 5 June 2024 (1 month ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Friday 17 May 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 7 May 2024 (2 months ago) • Edgar (US Regulatory)
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
Tuesday 7 May 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Monday 6 May 2024 (2 months ago) • Edgar (US Regulatory)
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
Monday 6 May 2024 (2 months ago) • GlobeNewswire Inc.
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
Monday 29 April 2024 (3 months ago) • GlobeNewswire Inc.
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
Monday 15 April 2024 (3 months ago) • GlobeNewswire Inc.
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
Monday 4 March 2024 (4 months ago) • GlobeNewswire Inc.
Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 27 February 2024 (5 months ago) • Edgar (US Regulatory)